Clinical Trial Update: A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of sodium zirconium cyclosilicate on CKD progression in participants with chronic kidney disease and hyperkalemia or at ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia

Drugs mentioned

• Sodium zirconium cyclosilicate (Lokelma) (Sodium zirconium cyclosilicate)

Snippet

Sponsor: AstraZeneca | Conditions: Renal Insufficiency, Chronic, Hyperkalemia | Phase 3 | Status: TERMINATED | Results posted: 2026-01-08